Comment on "Platelet-Rich Plasma as a novel therapeutic agent in osteomyelitis"

Medical Hypotheses

Volumn 73, Issue 2, 2009, Pages 270-271

  Jia, Weitao ^a   Zhang, Changqing ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; PEPTIDE; VASCULOTROPIN;

ANGIOGENESIS; ANTIMICROBIAL ACTIVITY; BONE REGENERATION; CHEMOTAXIS; DRUG MECHANISM; HOST RESISTANCE; HUMAN; LETTER; OSTEOMYELITIS; PRIORITY JOURNAL; THROMBOCYTE RICH PLASMA;

BLOOD TRANSFUSION; HUMANS; OSTEOMYELITIS; PLATELET-RICH PLASMA;

EID: 67349258648     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2009.02.012     Document Type: Letter

References (9)

1. Namazi H. Platelet-rich Plasma as a novel therapeutic agent in osteomyelitis. Med Hypotheses 69 3 (2007) 706
2. Everts P.A., Hoffmann J., Weibrich G., et al. Differences in platelet growth factor release and leucocyte kinetics during autologous platelet gel formation. Transfusion Med 16 5 (2006) 363-368
3. Lehrer R.I., Ganz T., Selsted M.E., Babior B.M., and Curnutte J.T. Neutrophils and host defense. Ann Intern Med 109 2 (1988) 127-142
4. Klinger M.H., and Jelkmann W. Role of blood platelets in infection and inflammation. J Interf Cytok Res 22 9 (2002) 913-922
5. Yeaman M.R., Bayer A.S., Koo S.P., Foss W., and Sullam P.M. Platelet microbicidal proteins and neutrophil defensin disrupt the Staphylococcus aureus cytoplasmic membrane by distinct mechanisms of action. J Clin Invest 101 1 (1998) 178-187
6. Kupferwasser L.I., Yeaman M.R., Shapiro S.M., Nast C.C., and Bayer A.S. In vitro susceptibility to thrombin-induced platelet microbicidal protein is associated with reduced disease progression and complication rates in experimental Staphylococcus aureus endocarditis: microbiologic, histologic, and echocardiographic analyses. Circulation 105 6 (2002) 746-752
7. Hancock R.E. Peptide antibiotics. Lancet 349 9049 (1997) 418-422
8. Dürr M., and Peschel A. Chemokines meet defensins: the merging concepts of chemoattractants and antimicrobial peptides in host defense. Infect Immun 70 12 (2002) 6515-6517
9. Anitua E., Sánchez M., Orive G., and Andía I. The potential impact of the preparation rich in growth factors (PRGF) in different medical fields. Biomaterials 28 31 (2007) 4551-4560